What Are the Challenges in Developing Nanostructured Drugs?
1. Safety and Toxicity: Long-term effects and potential toxicity of nanomaterials need thorough investigation. 2. Regulatory Hurdles: The regulatory landscape for nanomedicines is still evolving, requiring clear guidelines and standards. 3. Manufacturing and Scalability: Producing nanostructured drugs on a large scale with consistent quality remains a challenge. 4. Cost: The development and production of nanostructured drugs can be expensive, which may limit accessibility.
